Erlotinib may improve life quality in advanced NSCLC
Treating advanced epidermal growth factor receptor-mutation-positive non-small-cell lung cancer with erlotinib appears to improve quality of life compared with standard first-line chemotherapy, study results indicate.
Source: MedWire News - Lung Cancer - Category: Cancer & Oncology Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Lung Cancer | Non-Small Cell Lung Cancer | Study | Tarceva